Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

March 18, 2021

Study Completion Date

October 21, 2021

Conditions
Non-segmental Vitiligo
Interventions
DRUG

Ruxolitinib cream

Ruxolitinib cream is a topical formulation applied as a thin film to affected areas.

DRUG

Vehicle

Vehicle cream is a topical formulation applied as a thin film to affected areas.

Trial Locations (57)

10012

The Dermatology Specialists Greenwich, New York

11203

Suny Downstate Medical Center, Brooklyn

11375

Forest Hills Dermatology Group, Forest Hills

18016

Hospital Universitario San Cecilio, Granada

19008

Kgl Skin Study Center, Broomall

19462

Dermatology Associates of Plymouth Meeting, Plymouth Meeting

27157

Wake Forest University, Winston-Salem

27612

Wake Research Associates Llc, Raleigh

29621

Palmetto Clinical Trial Services, Anderson

31008

Clinica Universidad de Navarra (Cun), Pamplona

31059

Chu de Toulouse Hopital Larrey Centre de Reference Des Maladies Rares de La Peau Service de Dermatol, Toulouse

33014

San Marcus Research Clinic Inc., Miami Lakes

33016

Harmony Medical Research Institute, Hialeah

33401

Metabolic Research Institute Inc, West Palm Beach

33613

ForCare Medical Center, Tampa

33624

Forcare Clinical Research Fcr Forward Clinical Trials, Inc, Tampa

35244

Cahaba Dermatology, Hoover

37130

International Clinical Research Tennessee Llc, Murfreesboro

44000

Centre Hospitalier Universitaire de Nantes, Nantes

48114

Dermatology Specialists of Brighton, Brighton

48149

Universitatsklinik Munster Dermatologie, Münster

48706

Great Lakes Research Group Inc, Bay City

50125

Presidio Ospedaliero Piero Palagi, Florence

60611

Northwestern University, Chicago

70006

Clinical Trials Management Llc, Metairie

71913

Burke Pharmaceutical Research, Hot Springs

76031

Hopital Charles Nicolle Chu Rouen - Hopital de Bois-Guillaume, Rouen

78213

Progressive Clinical Research, San Antonio

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

85260

Cognitive Clinical Trials Scottsdale Btc Ppds, Scottsdale

92123

Rady Children'S Hospital - San Diego, San Diego

92647

Marvel Clinical Research Llc, Huntington Beach

92708

First Oc Dermatology, Fountain Valley

94158

University of California San Francisco Sub Location, San Francisco

99202

Dermatology Specialists of Spokane, Spokane

06810

Clinical Research Center of Ct, Danbury

05800

Multiprofile Hospital For Active Treatement - Clinic of Dermatology and Venerology, Pleven

01592

DCC 28, Sofia

01606

Medical Center Eurohealth, Sofia

T1Y 0B4

Dermatology Research Institute, Calgary

T3A 2N1

Institute For Skin Advancement, Calgary

K9J 5K2

Skin Centre For Dermatology, Peterborough

N8W 5L7

Windsor Clinical Research Inc, Windsor

H3Z2S6

McGill University Health Centre / Carey/Wang Clinic, Montreal

H3Z 2S6

Siena Medical Reserch Corporation, Westmount

06202

Chu de Nice - Hopital L'Archet 1, Nice

01307

University Clinic Carl Gustav Carus, Technical University Dresden, Dresden

00144

Istituto Dermatologico San Gallicano, Rome

80-382

Synexus - Polska Sp Z Oo Oddzial W Gdansk, Gdansk

81-537

Synexus Polska Sp. Z O.O. Oddzial W Gdyni, Gdynia

40-040

Synexus - Sp Z Oo Oddzial W Katowice, Katowice

27-400

Dermedic Dr. Zdybski, Ostrowiec

60-702

Synexus Polska Sp. Z O.O. Oddzial W Poznaniu, Poznan

87-100

Poradnia Dermatologiczno-Wenerologiczna Mediderm S.C. Nzoz, Torun

50-381

Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw

08034

Hospital Cima Sanitas, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY